{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:11:45Z","timestamp":1790424705520,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/21801-2"],"award-info":[{"award-number":["2017\/21801-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/16008-3"],"award-info":[{"award-number":["2014\/16008-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/18384-8"],"award-info":[{"award-number":["2016\/18384-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["301676\/2013-5"],"award-info":[{"award-number":["301676\/2013-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["142286\/2017"],"award-info":[{"award-number":["142286\/2017"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["401904\/2012-"],"award-info":[{"award-number":["401904\/2012-"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00280-020-04170-5","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T05:13:45Z","timestamp":1604380425000},"page":"1-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Artemisinin-type drugs for the treatment of hematological malignancies"],"prefix":"10.1007","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6725-3131","authenticated-orcid":false,"given":"R. I.","family":"Mancuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-4452","authenticated-orcid":false,"given":"M. A.","family":"Foglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0809-8068","authenticated-orcid":false,"given":"S. T.","family":"Olalla Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"4170_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"DL Klayman","year":"1985","unstructured":"Klayman DL (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science 228:1049\u20131055","journal-title":"Science"},{"key":"4170_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cell.2011.08.024","volume":"146","author":"LH Miller","year":"2011","unstructured":"Miller LH, Su X (2011) Artemisinin: discovery from the Chinese herbal garden. Cell 146:855\u2013858","journal-title":"Cell"},{"key":"4170_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201601967","author":"Y Tu","year":"2016","unstructured":"Tu Y (2016) Artemisinin\u2014a gift from traditional chinese medicine to the world (nobel lecture). Angew Chem. https:\/\/doi.org\/10.1002\/anie.201601967","journal-title":"Angew Chem"},{"key":"4170_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0140-6736(93)90362-K","volume":"341","author":"TT Hien","year":"1993","unstructured":"Hien TT, White NJ (1993) Qinghaosu. Lancet 341:603\u2013608","journal-title":"Lancet"},{"key":"4170_CR5","first-page":"767","volume":"18","author":"T Efferth","year":"2001","unstructured":"Efferth T, Dunstan F, Sauerbrey A, Miyachi H, Chitambar CR (2001) The anti-malarial artesunate is also active against cancer. Int J Oncol 18:767\u2013773","journal-title":"Int J Oncol"},{"key":"4170_CR6","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.18632\/oncotarget.6896","volume":"7","author":"JM Fox","year":"2016","unstructured":"Fox JM, Moynihan JR, Mott BT, Mazzone JR, Anders NM, Brown PA, Rudek MA, Liu JO, Arav-Borger R, Posner GH, Civin CI, Chen X (2016) Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. Oncotarget 7:7268\u20137279","journal-title":"Oncotarget"},{"key":"4170_CR7","doi-asserted-by":"publisher","unstructured":"Zhao X, Zhong H, Wang R, Liu D, Waxman S, Zhao L, Jing Y (2015) Dihydroartemisinin and its derivative induce apoptosis in acute myeloid leukemia through Noxa-mediated pathway requiring iron and endoperoxide moiety. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.3336","DOI":"10.18632\/oncotarget.3336"},{"key":"4170_CR8","doi-asserted-by":"publisher","unstructured":"Kim C, Lee JH, Kim S-H, Sethi G, Ahn KS (2015) Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.3004.","DOI":"10.18632\/oncotarget.3004"},{"key":"4170_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CAD.0000000000000697","volume":"30","author":"NS Lam","year":"2019","unstructured":"Lam NS, Long X, Wong JW, Griffin RC, Doery JCG (2019) Artemisinin and its derivatives: a potential treatment for leukemia. Anticancer Drugs 30:1\u201318","journal-title":"Anticancer Drugs"},{"key":"4170_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.02.009","author":"T Efferth","year":"2017","unstructured":"Efferth T (2017a) From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2017.02.009","journal-title":"Semin Cancer Biol"},{"key":"4170_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2017.03.019","author":"T Efferth","year":"2017","unstructured":"Efferth T (2017b) Cancer combination therapies with artemisinin-type drugs. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2017.03.019","journal-title":"Biochem Pharmacol"},{"key":"4170_CR12","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.2174\/1381612825666190902155957","volume":"25","author":"MS Kumar","year":"2019","unstructured":"Kumar MS, Yadav TT, Khair RR, Peters GJ, Yergeri MC (2019) Combination therapies of artemisinin and its derivatives as a viable approach for future cancer treatment. Curr Pharm Des 25:3323\u20133338","journal-title":"Curr Pharm Des"},{"key":"4170_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1055\/s-2002-32570","volume":"68","author":"MA Foglio","year":"2002","unstructured":"Foglio MA, Dias PC, Ant\u00f4nio MA, Possenti A, Ferreira Rodrigues RA, Ferreira da Silva E, Rehder VL, de Carvalho JE (2002) Antiulcerogenic activity of some sesquiterpene lactones isolated from artemisia annua. Planta Med 68:515\u2013518","journal-title":"Planta Med"},{"key":"4170_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5897\/JMPR2016.6318","volume":"11","author":"CS Ives","year":"2017","unstructured":"Ives CS, Pedro MM, Ilza MOS, Mary AF, Eduardo L, S\u00e9rgio NE, Chagas ACS (2017) Anthelmintic activity of Artemisia annua in sheep-model. J Med Plants Res 11:137\u2013143","journal-title":"J Med Plants Res"},{"key":"4170_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.reprotox.2007.11.003","volume":"25","author":"AC Boareto","year":"2008","unstructured":"Boareto AC, Muller JC, Bufalo AC, Botelho GGK, de Araujo SL, Foglio MA, de Morais RN, Dalsenter PR (2008) Toxicity of artemisinin [Artemisia annua L.] in two different periods of pregnancy in Wistar rats. Reprod Toxicol 25:239\u2013246","journal-title":"Reprod Toxicol"},{"key":"4170_CR16","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.xphs.2018.10.007","volume":"108","author":"F Volpe Zanutto","year":"2019","unstructured":"Volpe Zanutto F, McAlister E, Marucci Pereira Tangerina M, Fonseca-Santos B, Costa Salles TH, Oliveira Souza IM, Brisibe A, Vilegas W, Chorilli M, d\u2019\u00c1vila MA, Donnelly RF, Foglio MA (2019) Semisynthetic derivative of Artemisia annua-Loaded transdermal bioadhesive for the treatment of uncomplicated malaria caused by Plasmodium falciparum in children. J Pharm Sci 108:1177\u20131188","journal-title":"J Pharm Sci"},{"key":"4170_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.canlet.2017.11.006","volume":"414","author":"CO Torello","year":"2018","unstructured":"Torello CO, Shiraishi RN, Della Via FI, de Castro TCL, Longhini AL, Santos I, Bombeiro AL, Araujo Silva CL, Queiroz ML, Rego EM, Saad STO (2018) Reactive oxygen species production triggers green tea-induced anti-leukaemic effects on acute promyelocytic leukaemia model. Cancer Lett 414:116\u2013126","journal-title":"Cancer Lett"},{"key":"4170_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0563-3","author":"MC Alvarez","year":"2018","unstructured":"Alvarez MC, Maso V, Torello CO, Ferro KP, Saad STO (2018) The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes. Clin Epigenetics. https:\/\/doi.org\/10.1186\/s13148-018-0563-3","journal-title":"Clin Epigenetics"},{"key":"4170_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","volume":"22","author":"RL Bowman","year":"2018","unstructured":"Bowman RL, Busque L, Levine RL (2018) Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies. Cell Stem Cell 22:157\u2013170","journal-title":"Cell Stem Cell"},{"key":"4170_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.46","author":"SK Kumar","year":"2017","unstructured":"Kumar SK, Rajkumar V, Kyle RA, Van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC (2017) Multiple myeloma. Nat Rev Dis Prim. https:\/\/doi.org\/10.1038\/nrdp.2017.46","journal-title":"Nat Rev Dis Prim"},{"key":"4170_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F (2017) Non-Hodgkin lymphoma. Lancet 390:298\u2013310","journal-title":"Lancet"},{"key":"4170_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12020357","volume":"12","author":"C Gurnari","year":"2020","unstructured":"Gurnari C, Voso MT, Maciejewski JP, Visconte V (2020) From bench to bedside and beyond: therapeutic scenario in acute myeloid leukemia. Cancers (Basel) 12:1\u201320","journal-title":"Cancers (Basel)"},{"key":"4170_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M (2016) Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. https:\/\/doi.org\/10.1038\/bcj.2016.50","journal-title":"Blood Cancer J"},{"key":"4170_CR24","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.18632\/oncotarget.1847","volume":"5","author":"X Papanikolaou","year":"2014","unstructured":"Papanikolaou X, Johnson S, Garg T, Tian E, Tytarenko R, Zhang Q, Stein J, Barlogie B, Epstein J, Heuck C (2014) Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis. Oncotarget 5:4118\u20134128","journal-title":"Oncotarget"},{"key":"4170_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00280-016-3038-2","volume":"77","author":"CD Drenberg","year":"2016","unstructured":"Drenberg CD, Buaboonnam J, Orwick SJ, Hu S, Li L, Fan Y, Shelat AA, Guy RK, Rubnitz J, Baker SD (2016) Evaluation of artemisinins for the treatment of acute myeloid leukemia. Cancer Chemother Pharmacol 77:1231\u20131243","journal-title":"Cancer Chemother Pharmacol"},{"key":"4170_CR26","doi-asserted-by":"publisher","unstructured":"Zheng G-Q (1993) Cytotoxic terpenoids and flavonoids from Artemisia annua. Planta Med. https:\/\/doi.org\/10.1055\/s-2006-959408","DOI":"10.1055\/s-2006-959408"},{"key":"4170_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152998","author":"Y Wang","year":"2019","unstructured":"Wang Y, Li Y, Shang D, Efferth T (2019) Interactions between artemisinin derivatives and P-glycoprotein. Phytomedicine. https:\/\/doi.org\/10.1016\/j.phymed.2019.152998","journal-title":"Phytomedicine"},{"key":"4170_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1006\/bcmd.2002.0492","volume":"28","author":"T Efferth","year":"2002","unstructured":"Efferth T, Davey M, Olbrich A, R\u00fccker G, Gebhart E, Davey R (2002) Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells, Mol Dis 28:160\u2013168","journal-title":"Blood Cells, Mol Dis"},{"key":"4170_CR29","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1055\/s-0030-1271157","volume":"77","author":"NP Singh","year":"2011","unstructured":"Singh NP, Ferreira JFS, Park JS, Lai HC (2011) Cytotoxicity of ethanolic extracts of Artemisia annua to molt-4 human leukemia cells. Planta Med 77:1788\u20131793","journal-title":"Planta Med"},{"key":"4170_CR30","first-page":"3399","volume":"34","author":"M Wickerath","year":"2014","unstructured":"Wickerath M, Singh NP (2014) Additive cytotoxic effects of dihydroartemisinin and sodium salicylate on cancer cells. Anticancer Res 34:3399\u20133401","journal-title":"Anticancer Res"},{"key":"4170_CR31","first-page":"1867","volume":"35","author":"T Gerhardt","year":"2015","unstructured":"Gerhardt T, Jones R, Park J, Lu R, Chan HW, Fang Q, Singh N, Lai H (2015) Effects of antioxidants and pro-oxidants on cytotoxicity of dihydroartemisinin to Molt-4 human leukemia cells. Anticancer Res 35:1867\u20131872","journal-title":"Anticancer Res"},{"key":"4170_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.leukres.2017.05.007","volume":"59","author":"B Kumar","year":"2017","unstructured":"Kumar B, Kalvala A, Chu S, Rosen S, Forman SJ, Marcucci G, Chen CC, Pullarkat V (2017) Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia. Leuk Res 59:124\u2013135","journal-title":"Leuk Res"},{"key":"4170_CR33","first-page":"6047","volume":"37","author":"M Ohtaka","year":"2017","unstructured":"Ohtaka M, Itoh M, Tohda S (2017) BMI1 inhibitors down-regulate NOTCH signaling and suppress proliferation of acute leukemia cells. Anticancer Res 37:6047\u20136053","journal-title":"Anticancer Res"},{"key":"4170_CR34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ejh.12176","volume":"91","author":"T Holien","year":"2013","unstructured":"Holien T, Olsen OE, Misund K, Hella H, Waage A, R\u00f8 TB, Sudan A (2013) Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate. Eur J Haematol 91:339\u2013346","journal-title":"Eur J Haematol"},{"key":"4170_CR35","doi-asserted-by":"publisher","first-page":"9372","DOI":"10.1074\/jbc.M610375200","volume":"282","author":"AE Mercer","year":"2007","unstructured":"Mercer AE, Maggs JL, Sun XM, Cohen GM, Chadwick J, O\u2019Neill PM, Park BK (2007) Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. J Biol Chem 282:9372\u20139382","journal-title":"J Biol Chem"},{"key":"4170_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","volume":"131","author":"J Du","year":"2019","unstructured":"Du J, Wang T, Li Y, Zhou Y, Wang X, Yu X, Ren X, An Y, Wu Y, Sun W, Fan W, Zhu Q, Wang Y, Tong X (2019) DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radic Biol Med 131:356\u2013369","journal-title":"Free Radic Biol Med"},{"key":"4170_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00280-005-0002-y","volume":"57","author":"J Lee","year":"2006","unstructured":"Lee J, Zhou HJ, Wu XH (2006) Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells. Cancer Chemother Pharmacol 57:213\u2013230","journal-title":"Cancer Chemother Pharmacol"},{"key":"4170_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0960-894X(00)00578-3","volume":"11","author":"Y Li","year":"2001","unstructured":"Li Y, Shan F, Wu JM, Wu GS, Ding J, Xiao D, Yang WY, Atassi G, L\u00e9once S, Caignard DH, Renard P (2001) Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle. Bioorg Med Chen Lett 11:5\u20138","journal-title":"Bioorg Med Chen Lett"},{"key":"4170_CR39","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0968-0896(02)00538-2","volume":"11","author":"Y Li","year":"2003","unstructured":"Li Y, Wu JM, Shan F, Wu GS, Ding J, Xiao D, Han JX, Atassi G, Leonce S, Caignard DH, Renard P (2003) Synthesis and cytotoxicity of dihydroartemisinin ethers containing cyanoarylmethyl group. Bioorg Med Chem 11:977\u2013984","journal-title":"Bioorg Med Chem"},{"key":"4170_CR40","first-page":"2562","volume":"15","author":"Y Wang","year":"2018","unstructured":"Wang Y, Xu X, Wu X, Chen W, Huang F, Gui X (2018) Dihydroartemisinin treatment of multiple myeloma cells causes activation of c-jun leading to cell apoptosis. Oncol Lett 15:2562\u20132566","journal-title":"Oncol Lett"},{"key":"4170_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s12185-010-0697-3","volume":"92","author":"H Chen","year":"2010","unstructured":"Chen H, Shi L, Yang X, Li S, Guo X, Pan L (2010) Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells. Int J Hematol 92:587\u2013597","journal-title":"Int J Hematol"},{"key":"4170_CR42","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/01.cad.0000224443.85834.32","volume":"17","author":"XH Wu","year":"2006","unstructured":"Wu XH, Zhou HJ, Lee J (2006) Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion. Anticancer Drugs 17:839\u2013848","journal-title":"Anticancer Drugs"},{"key":"4170_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12185-009-0409-z","volume":"90","author":"S Li","year":"2009","unstructured":"Li S, Xue F, Cheng Z, Yang X, Wang S, Geng F, Pan L (2009) Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2\/0 myeloma cells through affecting NF\u03baB p65. Int J Hematol 90:513\u2013521","journal-title":"Int J Hematol"},{"key":"4170_CR44","first-page":"4083","volume":"14","author":"X Zhao","year":"2017","unstructured":"Zhao X, Guo X, Yue W, Wang J, Yang J, Chen J (2017) Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells. Exp Ther Med 14:4083\u20134090","journal-title":"Exp Ther Med"},{"key":"4170_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0561-0","author":"TK V\u00e5tsveen","year":"2018","unstructured":"V\u00e5tsveen TK, Myhre MR, Steen CB, W\u00e4lchli S, Lingj\u00e6rde OC, Bai B, Dillard P, Theodossiou TD, Holien T, Sudan A, Inderberg EM, Smeland EB, Myklebust JH, Oksvold MP (2018) Artesunate shows potent anti-tumor activity in B-cell lymphoma. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-018-0561-0","journal-title":"J Hematol Oncol"},{"key":"4170_CR46","first-page":"3059","volume":"15","author":"L Huo","year":"2018","unstructured":"Huo L, Wei W, Wu S, Zhao X, Zhao C, Zhao H, Sun L (2018) Effect of dihydroarteminin combined with siRNA targetingnotch1 on Notch1\/c-Myc signaling in T-cell lymphoma cells. Exp Ther Med 15:3059\u20133065","journal-title":"Exp Ther Med"},{"key":"4170_CR47","first-page":"6838","volume":"16","author":"W Wei","year":"2018","unstructured":"Wei W, Zhao X, Wu S, Zhao C, Zhao H, Sun L, Cui Y (2018) Dihydroartemisinin triggers c-Myc proteolysis and inhibits protein kinase B\/glycogen synthase kinase 3\u03b2 pathway in T-cell lymphoma cells. Oncol Lett 16:6838\u20136846","journal-title":"Oncol Lett"},{"key":"4170_CR48","first-page":"149","volume":"35","author":"S Sieber","year":"2009","unstructured":"Sieber S, Gdynia G, Roth W, Bona Vida B, Efferth T (2009) Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesuante. Int J Oncol 35:149\u2013158","journal-title":"Int J Oncol"},{"key":"4170_CR49","doi-asserted-by":"publisher","unstructured":"Ishikawa C, Senba M, Mori N (2020) Evaluation of artesunate for the treatment of adult T-cell leukemia\/lymphoma. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2020.172953","DOI":"10.1016\/j.ejphar.2020.172953"},{"key":"4170_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0304-3835(94)03716-V","volume":"91","author":"H Lai","year":"1995","unstructured":"Lai H, Singh NP (1995) Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91:41\u201346","journal-title":"Cancer Lett"},{"key":"4170_CR51","first-page":"4325","volume":"25","author":"NP Singh","year":"2005","unstructured":"Singh NP, Lai HC (2005) Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res 25:4325\u20134331","journal-title":"Anticancer Res"},{"key":"4170_CR52","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","volume":"37","author":"T Efferth","year":"2004","unstructured":"Efferth T, Benakis A, Romero MR, Tomicic M, Rauh R, Steinbach D, Hafer R, Stamminger T, Oesch F, Kaina B, Marschall M (2004) Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med 37:998\u20131009","journal-title":"Free Radic Biol Med"},{"key":"4170_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000798","author":"G Kelter","year":"2007","unstructured":"Kelter G, Steinbach D, Konkimalla VB, Tahara T, Taketani S, Fiebig HH, Efferth T (2007) Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0000798","journal-title":"PLoS ONE"},{"key":"4170_CR54","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.lfs.2004.08.020","volume":"76","author":"H Lai","year":"2005","unstructured":"Lai H, Sasaki T, Singh NP, Messay A (2005) Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci 76:1267\u20131279","journal-title":"Life Sci"},{"key":"4170_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2008.08.031","volume":"274","author":"S Oh","year":"2009","unstructured":"Oh S, Kim BJ, Singh NP, Lai H, Sasaki T (2009) Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Cancer Lett 274:33\u201339","journal-title":"Cancer Lett"},{"key":"4170_CR56","first-page":"2807","volume":"34","author":"J Park","year":"2014","unstructured":"Park J, Lai HC, Singh M, Sasaki T, Singh NP (2014) Development of a dihydroartemisinin-resistant molt-4 leukemia cell line. Anticancer Res 34:2807\u20132810","journal-title":"Anticancer Res"},{"key":"4170_CR57","first-page":"4467","volume":"30","author":"Y Ohgami","year":"2010","unstructured":"Ohgami Y, Elstad CA, Chung E, Shirachi DY, Quock RM, Lai HC (2010) Effect of hyperbaric oxygen on the anticancer effect of artemisinin on molt-4 human leukemia cells. Anticancer Res 30:4467\u20134470","journal-title":"Anticancer Res"},{"key":"4170_CR58","first-page":"1","volume":"10","author":"Q Wang","year":"2015","unstructured":"Wang Q, Wu S, Zhao X, Zhao C, Zhao H, Huo L (2015) Mechanisms of dihydroartemisinin and dihydroartemisinin\/holotransferrin cytotoxicity in T-cell lymphoma cells. PLoS ONE 10:1\u201312","journal-title":"PLoS ONE"},{"key":"4170_CR59","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.4161\/cbt.7.7.6035","volume":"7","author":"JJ Lu","year":"2008","unstructured":"Lu JJ, Meng LH, Cai YJ, Chen Q, Tong LJ, Lin LP, Ding J (2008) Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species. Cancer Biol Ther 7:1017\u20131023","journal-title":"Cancer Biol Ther"},{"key":"4170_CR60","doi-asserted-by":"publisher","unstructured":"Zhou H-J, Wang Z, Li A (2007) Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression. Anti Cancer Drugs. https:\/\/doi.org\/10.1097\/CAD.0b013e3282f3f152.","DOI":"10.1097\/CAD.0b013e3282f3f152"},{"key":"4170_CR61","first-page":"2277","volume":"24","author":"NP Singh","year":"2004","unstructured":"Singh NP, Lai HC (2004) Artemisinin induces apoptosis in human cancer cells. Anticancer Res 24:2277\u20132280","journal-title":"Anticancer Res"},{"key":"4170_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.fob.2012.05.002","volume":"2","author":"Z Wang","year":"2012","unstructured":"Wang Z, Hu W, Zhang JL, Wu XH, Zhou HJ (2012) Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity. FEBS Open Biol 2:103\u2013112","journal-title":"FEBS Open Biol"},{"key":"4170_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000693","author":"T Efferth","year":"2007","unstructured":"Efferth T, Glaisi M, Merling A, Krammer PH, Li-Weber M (2007) Artesunate induces ROS-mediated apoptosis in Doxorubicin-resistant T leukemia cells. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0000693","journal-title":"PLoS ONE"},{"key":"4170_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cbi.2010.03.021","volume":"186","author":"S Zhang","year":"2010","unstructured":"Zhang S, Chen H, Gerhard GS (2010) Heme synthesis increases artemisinin-induced radical formation and cytotoxicity that can be suppressed by superoxide scavengers. Chem Biol Interact 186:30\u201335","journal-title":"Chem Biol Interact"},{"key":"4170_CR65","first-page":"4389","volume":"33","author":"HW Chan","year":"2013","unstructured":"Chan HW, Singh NP, Lai HC (2013) Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine. Anticancer Res 33:4389\u20134394","journal-title":"Anticancer Res"},{"key":"4170_CR66","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2019.09.023","volume":"519","author":"N Wang","year":"2019","unstructured":"Wang N, Zeng GZ, Yin JL, Bian ZX (2019) Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt\u2019s lymphoma. Biochem Biophys Res Commun 519:533\u2013539","journal-title":"Biochem Biophys Res Commun"},{"key":"4170_CR67","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10495-011-0580-6","volume":"16","author":"N Gao","year":"2011","unstructured":"Gao N, Budhraja A, Cheng S, Liu EH, Huang C, Chen J, Yang Z, Chen D, Zhang Z, Shi X (2011) Interruption of the MEK\/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo. Apoptosis 16:511\u2013523","journal-title":"Apoptosis"},{"key":"4170_CR68","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00432-012-1292-1","volume":"138","author":"J Lee","year":"2012","unstructured":"Lee J, Zhang G, Wu X, Xu F, Zhou J, Zhang X (2012) Growth inhibitory effect of dihydroartemisinin on Bcr\/Abl+chronic myeloid leukemia K562 cells involve AKT, ERK and NF-\u03baB modulation. J Cancer Res Clin Oncol 138:2095\u20132102","journal-title":"J Cancer Res Clin Oncol"},{"key":"4170_CR69","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.biopha.2012.10.017","volume":"67","author":"J Lee","year":"2013","unstructured":"Lee J, Shen P, Zhang G, Wu X, Zhang X (2013) Dihydroartemisinin inhibits the Bcr\/Abl oncogene at the mRNA level in chronic myeloid leukemia sensitive or resistant to imatinib. Biomed Pharmacother 67:157\u2013163","journal-title":"Biomed Pharmacother"},{"key":"4170_CR70","doi-asserted-by":"publisher","first-page":"7558","DOI":"10.1158\/1078-0432.CCR-17-1231","volume":"23","author":"A Budhraja","year":"2017","unstructured":"Budhraja A, Turnis ME, Churchman ML, Kothari A, Yang X, Xu H, Kaminska E, Panetta JC, Finkelstein D, Mullighan CG, Opferman JT (2017) Modulation of navitoclax sensitivity by dihydroartemisinin-mediated MCL-1 repression in BCR-ABL+ B-lineage acute lymphoblastic leukemia. Clin Cancer Res 23:7558\u20137568","journal-title":"Clin Cancer Res"},{"key":"4170_CR71","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/onc.2016.196","volume":"36","author":"S Elf","year":"2017","unstructured":"Elf S, Lin R, Xia S, Pan Y, Shan C, Wu S, Lonial S, Gaddh M, Arellano ML, Khoury HJ, Khuri FR, Lee BH, Boggon TJ, Fan J, Chen J (2017) Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin. Oncogene 36:254\u2013262","journal-title":"Oncogene"},{"key":"4170_CR72","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3109\/10428194.2013.829573","volume":"55","author":"Y Li","year":"2014","unstructured":"Li Y, Feng L, Jiang W, Shan N, Wang X (2014) Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide. Leuk Lymphoma 55:1366\u20131372","journal-title":"Leuk Lymphoma"},{"key":"4170_CR73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.leukres.2017.09.022","volume":"62","author":"M Tan","year":"2017","unstructured":"Tan M, Rong Y, Su Q, Chen Y (2017) Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells. Leuk Res 62:98\u2013103","journal-title":"Leuk Res"},{"key":"4170_CR74","first-page":"3178","volume":"15","author":"JT Cao","year":"2018","unstructured":"Cao JT, Mo HM, Wang Y, Zhao K, Zhang TT, Wang CQ, Xu KL, Han ZH (2018) Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells. Oncol Lett 15:3178\u20133184","journal-title":"Oncol Lett"},{"key":"4170_CR75","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1158\/1535-7163.MCT-10-0051","volume":"9","author":"R Handrick","year":"2010","unstructured":"Handrick R, Ontikatze T, Bauer KD, Freier F, R\u00fcbel A, D\u00fcrig J, Belka C, Jendrossek V (2010) Dihydroartemisinin induces apoptosis by a bak-dependent intrinsic pathway. Mol Cancer Ther 9:2497\u20132510","journal-title":"Mol Cancer Ther"},{"key":"4170_CR76","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/med.21580","volume":"39","author":"X Sun","year":"2019","unstructured":"Sun X, Yan P, Zou C, Wong YK, Shu Y, Lee YM, Zhang C, Yang ND, Wang J, Zhang J (2019) Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives. Med Res Rev 39:2172\u20132193","journal-title":"Med Res Rev"},{"key":"4170_CR77","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/cam4.1276","volume":"7","author":"C Cheng","year":"2018","unstructured":"Cheng C, Wang T, Song Z, Peng L, Gao M, Hermine O, Rousseaux S, Khochbin S, Mi JQ, Wang J (2018) Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044. Cancer Med 7:380\u2013396","journal-title":"Cancer Med"},{"key":"4170_CR78","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.canlet.2013.09.035","volume":"343","author":"W Hu","year":"2014","unstructured":"Hu W, Chen SS, Zhang JL, Lou XE, Zhou HJ (2014) Dihydroartemisinin induces autophagy by suppressing NF-\u03baB activation. Cancer Lett 343:239\u2013248","journal-title":"Cancer Lett"},{"key":"4170_CR79","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","volume":"11","author":"JL Roh","year":"2017","unstructured":"Roh JL, Kim EH, Jang H, Shin D (2017) Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol 11:254\u2013262","journal-title":"Redox Biol"},{"key":"4170_CR80","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.2147\/DDDT.S199459","volume":"13","author":"K Wang","year":"2019","unstructured":"Wang K, Zhang Z, Wang M, Cao X, Qi J, Wang D, Gong A, Zhu H (2019) Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells. Drug Des Dev Ther 13:2135\u20132144","journal-title":"Drug Des Dev Ther"},{"key":"4170_CR81","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3892\/ijmm.2017.3085","volume":"40","author":"T Wei","year":"2017","unstructured":"Wei T, Liu J (2017) Anti-angiogenic properties of artemisinin derivatives. Int J Mol Med 40:972\u2013978","journal-title":"Int J Mol Med"},{"key":"4170_CR82","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.vph.2007.05.002","volume":"47","author":"HJ Zhou","year":"2007","unstructured":"Zhou HJ, Wang WQ, Wu GD, Lee J, Li A (2007) Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vascul Pharmacol 47:131\u2013138","journal-title":"Vascul Pharmacol"},{"key":"4170_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejphar.2003.09.057","volume":"482","author":"SH Kim","year":"2003","unstructured":"Kim SH, Kim HJ, Kim TS (2003) Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin. Eur J Pharmacol 482:67\u201376","journal-title":"Eur J Pharmacol"},{"key":"4170_CR84","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2008.03.036","volume":"587","author":"SH Kim","year":"2008","unstructured":"Kim SH, Chun SY, Kim TS (2008) Interferon-\u03b1 enhances artemisinin-induced differentiation of HL-60 leukemia cells via a PKC\u03b1\/ERK pathway. Eur J Pharmacol 587:65\u201372","journal-title":"Eur J Pharmacol"},{"key":"4170_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tox.2012.05.024","volume":"300","author":"S Finaurini","year":"2012","unstructured":"Finaurini S, Basilico N, Corbett Y, D\u2019Alessandro S, Parapini S, Olliaro P, Haynes RK, Taramelli D (2012) Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle. Toxicology 300:57\u201366","journal-title":"Toxicology"},{"key":"4170_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.05.016","author":"X Lu","year":"2020","unstructured":"Lu X, Efferth T (2020) Repurposing of artemisinin-type drugs for the treatment of acute leukemia. Semin Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.016","journal-title":"Semin Cancer Biol"},{"key":"4170_CR87","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1021\/jm100404t","volume":"53","author":"C Horwedel","year":"2010","unstructured":"Horwedel C, Tsogoeva SB, Wei S, Efferth T (2010) Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells. J Med Chem 53:4842\u20134848","journal-title":"J Med Chem"},{"key":"4170_CR88","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1016\/j.bmcl.2009.05.076","volume":"19","author":"X Yang","year":"2009","unstructured":"Yang X, Wang W, Tan J, Song D, Li M, Liu D, Jing Y, Zhao L (2009) Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells. Bioorg Med Chem Lett 19:4385\u20134388","journal-title":"Bioorg Med Chem Lett"},{"key":"4170_CR89","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejmech.2016.06.035","volume":"122","author":"R Gaur","year":"2016","unstructured":"Gaur R, Pathania AS, Malik FA, Bhakuni RS, Verma RK (2016) Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity. Eur J Med Chem 122:232\u2013246","journal-title":"Eur J Med Chem"},{"key":"4170_CR90","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1016\/j.bmc.2010.02.035","volume":"18","author":"J Chadwick","year":"2010","unstructured":"Chadwick J, Jones M, Mercer AE, Stocks PA, Ward SA, Park BK, O\u2019Neill PM (2010) Design, synthesis and antimalarial\/anticancer evaluation of spermidine linked artemisinin conjugates designed to exploit polyamine transporters in Plasmodium falciparum and HL-60 cancer cell lines. Bioorg Med Chem 18:2586\u20132597","journal-title":"Bioorg Med Chem"},{"key":"4170_CR91","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.bmc.2013.04.027","volume":"21","author":"BT Mott","year":"2013","unstructured":"Mott BT, He R, Chen X, Fox JM, Civin CI, Arav-Boger R, Posner GH (2013) Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: A structure-activity study. Bioorg Med Chem 21:3702\u20133707","journal-title":"Bioorg Med Chem"},{"key":"4170_CR92","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","volume":"23","author":"C Reiter","year":"2015","unstructured":"Reiter C, Fr\u00f6hlich T, Gruber L, Hutterer C, Marschall M, Voigtl\u00e4nder C, Friedrich O, Kappes O, Efferth T, Tsogoeva, (2015) Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities. Bioorg Med Chem 23:5452\u20135458","journal-title":"Bioorg Med Chem"},{"key":"4170_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040841","author":"L Gruber","year":"2018","unstructured":"Gruber L, Abdelfatah S, Frohlich T, Reiter C, Klein V, Tsogoeva SB, Efferth T (2018) Treatment of multidrug-resistant leukemia cells by novel artemisinin-, egonol-, and thymoquinone-derived hybrid compounds. Molecules. https:\/\/doi.org\/10.3390\/molecules23040841","journal-title":"Molecules"},{"key":"4170_CR94","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1016\/j.bmc.2012.07.015","volume":"20","author":"C Reiter","year":"2012","unstructured":"Reiter C, Herrmann A, \u00c7apci A, Efferth T, Tsogoeva SB (2012) New artesunic acid homodimers: Potent reversal agents of multidrug resistance in leukemia cells. Bioorg Med Chem 20:5637\u20135641","journal-title":"Bioorg Med Chem"},{"key":"4170_CR95","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1016\/j.bmc.2017.04.021","volume":"25","author":"AS Letis","year":"2017","unstructured":"Letis AS, Seo EJ, Nikolaropoulos SS, Efferth T, Giannis A, Fousteris MA (2017) Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells. Bioorg Med Chem 25:3357\u20133367","journal-title":"Bioorg Med Chem"},{"key":"4170_CR96","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ejmech.2014.01.043","volume":"75","author":"C Reiter","year":"2014","unstructured":"Reiter C, \u00c7apci Karag\u00f6z A, Fr\u00f6hlich T, Klein V, Zeino M, Viertel K, Held J, Mordmuller OSE, Anil H, Efferth T, Tsoegoeva SB (2014) Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. Eur J Med Chem 75:403\u2013412","journal-title":"Eur J Med Chem"},{"key":"4170_CR97","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","volume":"97","author":"C Reiter","year":"2015","unstructured":"Reiter C, Fr\u00f6hlich T, Zeino M, Marschall M, Bahsi H, Leidenberger M, Friedrich O, Kappes B, Hampel F, Efferth T, Tsogoeva SB (2015) New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. Eur J Med Chem 97:164\u2013172","journal-title":"Eur J Med Chem"},{"issue":"66","key":"4170_CR98","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bioorg.2016.03.008","volume":"1","author":"VT Ha","year":"2016","unstructured":"Ha VT, Kien VT, Binh LH, Tien VD, My NTT, Nam NH, Baltas M, Hahn H, Han BW, Thao DT, Vu TK (2016) Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton. Bioorg Chem 1(66):63\u201371. https:\/\/doi.org\/10.1016\/j.bioorg.2016.03.008","journal-title":"Bioorg Chem"},{"key":"4170_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040841","author":"Y Wu","year":"2018","unstructured":"Wu Y, Parapini S, Williams ID, Misiano P, Wong HN, Taramelli D, Basilico N, Haynes RK (2018) Facile preparation of N-glycosylated 10-piperazinyl artemisinin derivatives and evaluation of their antimalarial and cytotoxic Activities. Molecules. https:\/\/doi.org\/10.3390\/molecules23040841","journal-title":"Molecules"},{"key":"4170_CR100","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1021\/acsomega.7b00310","volume":"2","author":"T Fr\u00f6hlich","year":"2017","unstructured":"Fr\u00f6hlich T, Reiter C, Ibrahim MM, Beutel J, Hutterer C, Zeittr\u00e4ger I, Bahsi H, Leidenberger M, Friedrich O, Kappes B, Efferth T, Marschall M, Tsogoeva SB (2017) Synthesis of novel hybrids of quinazoline and artemisinin with high activities against plasmodium falciparum, human cytomegalovirus, and leukemia cells. ACS Omega 2:2422\u20132431","journal-title":"ACS Omega"},{"key":"4170_CR101","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/acsmedchemlett.7b00412","volume":"9","author":"T Fr\u00f6hlich","year":"2018","unstructured":"Fr\u00f6hlich T, Reiter C, Saeed MEM, Hutterer C, Hahn F, Leidenberger M, Friedrich O, Kappes B, Marschall M, Efferth T, Tsogoeva SB (2018) Synthesis of thymoquinone-artemisinin hybrids: new potent antileukemia, antiviral, and antimalarial agents. ACS Med Chem Lett 9:534\u2013539","journal-title":"ACS Med Chem Lett"},{"key":"4170_CR102","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1016\/j.bmc.2018.05.041","volume":"26","author":"A \u00c7apc\u0131 Karag\u00f6z","year":"2018","unstructured":"\u00c7apc\u0131 Karag\u00f6z A, Reiter C, Seo EJ, Gruber L, Hahn F, Leidenberger M, Klein V, Hampel F, Friedrich O, Marschall M, Kappes B, Efferth T, Tsogoeva SB (2018) Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin. Bioorg Med Chem 26:3610\u20133618","journal-title":"Bioorg Med Chem"},{"key":"4170_CR103","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1021\/ja00126a042","volume":"117","author":"GH Posner","year":"1995","unstructured":"Posner GH, Cumming JN, Ploypradith P, Oh CH (1995) Evidence for Fe(IV)=O in the molecular mechanism of action of the trioxane antimalarial artemisinin. J Am Chem Soc 117:5885\u20135886","journal-title":"J Am Chem Soc"},{"key":"4170_CR104","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nature01813","volume":"424","author":"U Eckstein-Ludwig","year":"2003","unstructured":"Eckstein-Ludwig U, Webb RJ, van Goethem DA, East JM, Lee AG, Kimura M, O\u2019Neill PM, Bray PG, Ward SA, Krishna S (2003) Artemisinin target the SERCA of Plasmodium falciparum. Nature 424:957\u2013961","journal-title":"Nature"},{"key":"4170_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06221-1","author":"JL Bridgford","year":"2018","unstructured":"Bridgford JL, Xie SC, Cobbold SA, Pasaje CFA, Herrmann S, Yang T, Gillett DL, Dick LR, Ralph SA, Dogovski C, Spillman NJ, Tilley L (2018) Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-06221-1","journal-title":"Nat Commun"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04170-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-020-04170-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04170-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T07:39:33Z","timestamp":1697009973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-020-04170-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4170"],"URL":"https:\/\/doi.org\/10.1007\/s00280-020-04170-5","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}